PATENT CLAIM ANALYSIS

Application Number: 16005228
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["435", "006140"]

Abstract:
Methods of distinguishing and identifying a patient with aggressive/indolent, prostatic adenocarcinoma comprising contacting a sample from the patient with a set of detectably labeled probes under hybridization conditions and determining the presence of chromosomal abnormalities in the sample; sets of probes for use in such methods; and kits comprising a set of probes and instructions for distinguishing or identifying a patient as having aggressive/indolent, prostatic adenocarcinoma.

Claim (Index 26):
A method comprising determining the copy number of the CMYC, ERG, and FGFR1 genes in a prostate adenocarcinoma sample by contacting the sample with detectably labeled probes that hybridize to one or more regions of the CMYC, ERG, and FGFR1 genes and performing fluorescence in situ hybridization.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.73171
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14788195', '13721081', '15443499', '14207682', '13721076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6390063233025804
- 35 USC 102 Novelty (BERT): 0.6084868312757103
- Combined Prediction Score: 0.6359543740998935
- Mean Citation Score: 403.382844
- Max Citation Score: 625.5991
- Similarity Product: 475.0032229003906

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test